Stephen S. Whitehead

11.9k total citations · 1 hit paper
140 papers, 8.4k citations indexed

About

Stephen S. Whitehead is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Stephen S. Whitehead has authored 140 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Public Health, Environmental and Occupational Health, 110 papers in Infectious Diseases and 31 papers in Epidemiology. Recurrent topics in Stephen S. Whitehead's work include Mosquito-borne diseases and control (112 papers), Viral Infections and Vectors (101 papers) and Malaria Research and Control (56 papers). Stephen S. Whitehead is often cited by papers focused on Mosquito-borne diseases and control (112 papers), Viral Infections and Vectors (101 papers) and Malaria Research and Control (56 papers). Stephen S. Whitehead collaborates with scholars based in United States, Australia and United Kingdom. Stephen S. Whitehead's co-authors include Brian R. Murphy, Anna P. Durbin, Joseph E. Blaney, Peter L. Collins, Christopher T. Hanson, Cai-Yen Firestone, Michael N. Teng, Kathryn A. Hanley, Alexander Bukreyev and Ruth A. Karron and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Stephen S. Whitehead

138 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prospects for a dengue virus vaccine

2007 477 citations Stephen S. Whitehead, Joseph E. Blaney et al. profile →

Peers

Countries citing papers authored by Stephen S. Whitehead

Since Specialization

Citations

This map shows the geographic impact of Stephen S. Whitehead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen S. Whitehead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen S. Whitehead more than expected).

Fields of papers citing papers by Stephen S. Whitehead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen S. Whitehead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen S. Whitehead. The network helps show where Stephen S. Whitehead may publish in the future.

Co-authorship network of co-authors of Stephen S. Whitehead

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen S. Whitehead. A scholar is included among the top collaborators of Stephen S. Whitehead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen S. Whitehead. Stephen S. Whitehead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of the sensitivity and specificity of commercial anti-dengue virus IgG tests to identify persons eligible for dengue vaccination 2024 ·Journal of Clinical Microbiology ·Freddy A. Medina, (unknown), Laura E. Adams, (unknown), (unknown), Elaine W. Lamirande, (unknown), (unknown), Manuela Beltrán, (unknown), Vanessa Rivera‐Amill, (unknown), Eva Harris, Zachary J. Madewell, Stephen H. Waterman, Gabriela Paz‐Bailey, Stephen S. Whitehead, Jorge L. Muñoz‐Jordán	2
2	Antigenic distance between primary and secondary dengue infections correlates with disease risk 2024 ·Science Translational Medicine ·Lin Wang, Angkana T. Huang, Leah C. Katzelnick, Noémie Lefrancq, (unknown), (unknown), (unknown), Richard G. Jarman, Matthew A. Conte, Irina Maljkovic Berry, Stefan Fernandez, Chonticha Klungthong, Butsaya Thaisomboonsuk, Piyarat Suntarattiwong, (unknown), Stephen S. Whitehead, Simon Cauchemez, Derek A. T. Cummings, Henrik Salje	11
3	Simultaneous quantitation of neutralizing antibodies against all four dengue virus serotypes using optimized reporter virus particles 2024 ·Journal of Virology ·(unknown), Emérito Amaro-Carambot, Elaine W. Lamirande, Theodore C. Pierson, Stephen S. Whitehead	2
4	Multiplex sample-sparing assay for detecting type-specific antibodies to Zika and dengue viruses: an assay development and validation study 2024 ·The Lancet Microbe ·(unknown), (unknown), Freddy A. Medina, (unknown), Bruno Segovia-Chumbez, Jorge L. Muñoz‐Jordán, Stephen S. Whitehead, Laura E. Adams, Gabriela Paz‐Bailey, Aravinda M. de Silva, (unknown)	6
5	TV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies 2023 ·Journal of Clinical Investigation ·Kristen K. Pierce, Anna P. Durbin, (unknown), Marya P. Carmolli, Beulah P. Sabundayo, Dorothy M. Dickson, Sean A. Diehl, Stephen S. Whitehead, Beth D. Kirkpatrick	14
6	Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection 2023 ·SHILAP Revista de lepidopterología ·(unknown), Tanvi Agrawal, (unknown), (unknown), Parveen Kumar, Anish Khan, (unknown), Balwant Singh, Chitra Pattabiraman, (unknown), Rajesh Pandey, Anmol Chandele, Rakesh Lodha, Stephen S. Whitehead, Guruprasad R. Medigeshi	6
7	Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial 2023 ·The Lancet Infectious Diseases ·(unknown), Mohammad Shafiul Alam, Kristen K. Pierce, Marya P. Carmolli, Masud Alam, Dorothy M. Dickson, (unknown), (unknown), (unknown), Golam Kibria, Firdausi Qadri, Sean A. Diehl, Anna P. Durbin, Stephen S. Whitehead, Rashidul Haque, Beth D. Kirkpatrick	23
8	Antigenic evolution of dengue viruses over 20 years 2021 ·Science ·Leah C. Katzelnick, (unknown), Angkana T. Huang, Bernardo García‐Carreras, (unknown), Irina Maljkovic Berry, (unknown), Philippe Buchy, Veasna Duong, Philippe Dussart, Gregory D. Gromowski, Louis Macareo, Butsaya Thaisomboonsuk, Stefan Fernandez, Derek J. Smith, Richard G. Jarman, Stephen S. Whitehead, Henrik Salje, Derek A. T. Cummings	38
9	Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model 2021 ·Nature Communications ·John Hanley, (unknown), Julie A. Dragon, Dorothy M. Dickson, Roxana del Río, Scott Tighe, Korin Eckstrom, (unknown), Samuel V. Scarpino, Stephen S. Whitehead, Anna P. Durbin, Kristen K. Pierce, Beth D. Kirkpatrick, Donna M. Rizzo, Seth Frietze, Sean A. Diehl	23
10	Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model 2019 ·EBioMedicine ·Usha K. Nivarthi, (unknown), (unknown), Jesica Swanstrom, B. L. Patel, Anna P. Durbin, Stephen S. Whitehead, Kristen K. Pierce, Beth D. Kirkpatrick, Ralph S. Baric, Ngan Nguyen, Daniel Emerling, Aravinda M. de Silva, Sean A. Diehl	23
11	Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus 2018 ·PLoS neglected tropical diseases ·Leah C. Katzelnick, (unknown), Benjamin D. McElvany, (unknown), Henrik Salje, Wensheng Luo, Isabel Rodríguez-Barraquer, Richard G. Jarman, Anna P. Durbin, Sean A. Diehl, Derek J. Smith, Stephen S. Whitehead, Derek A. T. Cummings	45
12	Methods to discriminate primary from secondary dengue during acute symptomatic infection 2018 ·BMC Infectious Diseases ·Thi Hanh Tien Nguyen, Hannah Clapham, Phung Khanh Lam, (unknown), (unknown), (unknown), (unknown), Stephen S. Whitehead, Cameron P. Simmons, Marcel Wolbers, Bridget Wills	34
13	Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization 2018 ·Cell Reports ·Emily N. Gallichotte, (unknown), Usha K. Nivarthi, (unknown), Rachel L. Graham, Douglas G. Widman, Boyd L. Yount, Anna P. Durbin, Stephen S. Whitehead, Aravinda M. de Silva, Ralph S. Baric	47
14	In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination 2017 ·PLoS neglected tropical diseases ·Stephen S. Whitehead, Anna P. Durbin, Kristen K. Pierce, (unknown), Benjamin D. McElvany, (unknown), Marya P. Carmolli, Cecilia Tibery, Noreen A. Hynes, (unknown), (unknown), Catherine J. Larsson, (unknown), Dorothy M. Dickson, Catherine J. Luke, Kanta Subbarao, Sean A. Diehl, Beth D. Kirkpatrick	80
15	A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial 2013 ·The Journal of Infectious Diseases ·Anna P. Durbin, Beth D. Kirkpatrick, Kristen K. Pierce, (unknown), Catherine J. Larsson, Janet C. Lindow, Cecilia Tibery, Beulah P. Sabundayo, Donna Shaffer, Kawsar R. Talaat, Noreen A. Hynes, Kimberli Wanionek, Marya P. Carmolli, Catherine J. Luke, Brian R. Murphy, Kanta Subbarao, Stephen S. Whitehead	129
16	Corticosteroids for Dengue – Why Don't They Work? 2013 ·PLoS neglected tropical diseases ·Thi Hanh Tien Nguyen, (unknown), (unknown), (unknown), Jeremy Farrar, (unknown), (unknown), (unknown), Phung Khanh Lam, Marcel Wolbers, Stephen S. Whitehead, Martin L. Hibberd, Bridget Wills, Cameron P. Simmons	28
17	Primary Vaccination with Low Dose Live Dengue 1 Virus Generates a Proinflammatory, Multifunctional T Cell Response in Humans 2012 ·PLoS neglected tropical diseases ·Janet C. Lindow, (unknown), Anna P. Durbin, Stephen S. Whitehead, Kelly A. Fimlaid, Janice Y. Bunn, Beth D. Kirkpatrick	34
18	Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2 2004 ·BMC Infectious Diseases ·Joseph E. Blaney, Christopher T. Hanson, Kathryn A. Hanley, Brian R. Murphy, Stephen S. Whitehead	64
19	Contribution of the Respiratory Syncytial Virus G Glycoprotein and Its Secreted and Membrane-Bound Forms to Virus Replication in Vitro and in Vivo 2001 ·Virology ·Michael N. Teng, Stephen S. Whitehead, Peter L. Collins	182
20	Nucleotide Sequence Analysis of the Respiratory Syncytial Virus Subgroup A Cold-Passaged (cp) Temperature Sensitive (ts)cpts-248/404 Live Attenuated Virus Vaccine Candidate 1996 ·Virology ·Cai-Yen Firestone, Stephen S. Whitehead, Peter L. Collins, Brian R. Murphy, James E. Crowe	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact